Nanoparticle-delivered RNA reduces neuroinflammation in lab tests

Some COVID-19 vaccines safely and effectively used lipid nanoparticles (LNPs) to deliver messenger RNA to cells. A new MIT study shows that different nanoparticles could be used for a potential Alzheimer's disease (AD) therapy. ...

page 8 from 40